Global Pharmatech, Inc.
GBLP · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $100 | $62 | $138 | $138 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $101 | $62 | $138 | $138 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -4.7% | -82.1% | 27.5% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 51.2% | -20.1% | 13.5% | 4.6% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 25.3% | -66.8% | -0.1% | -28.3% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 18.2% | -95.3% | -0.3% | -28.9% |
| EPS Diluted | 0 | -0 | 0 | -0 |
| % Growth | 100% | – | 100% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |